Mereo BioPharma (MREO) Shares Outstanding (2018 - 2026)

Mereo BioPharma (MREO) has 9 years of Shares Outstanding data on file, last reported at $798.1 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $798.1 million, changed 0.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $798.1 million (changed 0.39% YoY), and the FY2025 annual result was $795.7 million, up 2.57% from the prior year.
• Shares Outstanding held at $798.1 million in Q1 2026 per MREO's latest filing, from $795.7 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $798.1 million in Q1 2026 and troughed at $1.0 million in Q3 2023.
• A 5-year average of $693.0 million and a median of $771.2 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding tumbled 99.85% in 2022, then surged 69823.08% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $1.2 million in 2022, then jumped by 59502.86% to $701.2 million in 2023, then increased by 10.63% to $775.7 million in 2024, then rose by 2.57% to $795.7 million in 2025, then grew by 0.3% to $798.1 million in 2026.
• Business Quant data shows MREO's Shares Outstanding at $798.1 million in Q1 2026, $795.7 million in Q4 2025, and $795.5 million in Q3 2025.